Wisniewski T - Search Results

1

The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.

Reiss AB, Ahmed S, Dayaramani C, Glass AD, Gomolin IH, Pinkhasov A, Stecker MM, Wisniewski T, De Leon J. Reiss AB, et al. Among authors: wisniewski t. Exp Gerontol. 2022 Jul;164:111828. doi: 10.1016/j.exger.2022.111828. Epub 2022 May 1. Exp Gerontol. 2022. PMID: 35508280 Review.

2

Immunization treatment approaches in Alzheimer's and prion diseases.

Wisniewski T, Sigurdsson EM. Wisniewski T, et al. Curr Neurol Neurosci Rep. 2002 Sep;2(5):400-4. doi: 10.1007/s11910-002-0065-7. Curr Neurol Neurosci Rep. 2002. PMID: 12169219 Review.

3

Links between the pathology of Alzheimer's disease and vascular dementia.

Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T. Sadowski M, et al. Among authors: wisniewski t. Neurochem Res. 2004 Jun;29(6):1257-66. doi: 10.1023/b:nere.0000023612.66691.e6. Neurochem Res. 2004. PMID: 15176482

4

Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.

Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH, Duff K, Nixon RA, Gruen RJ, Wisniewski T. Sadowski M, et al. Among authors: wisniewski t. J Neuropathol Exp Neurol. 2004 May;63(5):418-28. doi: 10.1093/jnen/63.5.418. J Neuropathol Exp Neurol. 2004. PMID: 15198121

5

Immunological and anti-chaperone therapeutic approaches for Alzheimer disease.

Wisniewski T, Frangione B. Wisniewski T, et al. Brain Pathol. 2005 Jan;15(1):72-7. doi: 10.1111/j.1750-3639.2005.tb00102.x. Brain Pathol. 2005. PMID: 15779239 Free PMC article. Review.

6

Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.

Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, Quartermain D, Wisniewski T. Sadowski MJ, et al. Among authors: wisniewski t. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18787-92. doi: 10.1073/pnas.0604011103. Epub 2006 Nov 20. Proc Natl Acad Sci U S A. 2006. PMID: 17116874 Free PMC article.

7

Disease modifying approaches for Alzheimer's pathology.

Sadowski M, Wisniewski T. Sadowski M, et al. Among authors: wisniewski t. Curr Pharm Des. 2007;13(19):1943-54. doi: 10.2174/138161207781039788. Curr Pharm Des. 2007. PMID: 17627527 Review.

8

Vaccination as a therapeutic approach to Alzheimer's disease.

Wisniewski T, Boutajangout A. Wisniewski T, et al. Mt Sinai J Med. 2010 Jan-Feb;77(1):17-31. doi: 10.1002/msj.20156. Mt Sinai J Med. 2010. PMID: 20101719 Free PMC article. Review.

9

Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.

Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T. Chung E, et al. Among authors: wisniewski t. BMC Neurosci. 2010 Oct 14;11:130. doi: 10.1186/1471-2202-11-130. BMC Neurosci. 2010. PMID: 20946660 Free PMC article.

10

Active immunotherapy for Alzheimer's disease.

Wisniewski T. Wisniewski T. Lancet Neurol. 2012 Jul;11(7):571-2. doi: 10.1016/S1474-4422(12)70136-9. Epub 2012 Jun 6. Lancet Neurol. 2012. PMID: 22677257 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters